Drugs / mRNA-transfected autologous dendritic cells
mRNA-transfected autologous dendritic cells
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00833781 Comparator | Aug 2009 → Dec 2013 | HIV infectious disease | Massachusetts General Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-transfected autologous dendritic cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00833781 ↗ |
| Modality | Vaccine | “A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects” NCT00833781 ↗ |